Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglivance GM 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

OAK Vance Life Sciences Pvt. Ltd.

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Voglivance GM 2mg/500mg/0.2mg Tablet

Diabetic patients may find relief with the anti-diabetic medication, Voglivance GM 2mg/500mg/0.2mg Tablet, a combination drug formulated for adult type 2 diabetes management. This medication helps regulate blood sugar; consistent daily use, at the same time each day and with food, is crucial for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood glucose monitoring. Discontinuing this medicine without consulting your doctor is strongly discouraged, as this can lead to elevated blood sugar, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. Remember, Voglivance GM is one component of a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Hypoglycemia (low blood sugar) is the most frequent adverse reaction, manifesting as sweating, dizziness, headache, and tremors. Carry a readily available fast-acting sugar source (e.g., candy, juice) to counter this. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor of any history of heart disease before initiating treatment; pregnancy or breastfeeding also require medical consultation. Regular blood glucose checks and blood tests (monitoring blood cell counts and liver function) are necessary.

Primary Ingredients of Voglivance GM 2mg/500mg/0.2mg Tablet

The provided text is "undefined," offering no content to rephrase.

Uses of Voglivance GM 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Voglivance GM 2mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Voglivance GM 2mg/500mg/0.2mg Tablets. Ingest the tablets whole; do not chew, crush, or divide them. Administer on an empty stomach.

Common Side effects of Voglivance GM 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglivance GM 2mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Voglivance GM 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.

How Voglivance GM 2mg/500mg/0.2mg Tablet works:

Each Voglivance GM tablet (2mg/500mg/0.2mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voglivance GM 2mg/500mg/0.2mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voglivance GM 2mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Voglivance GM 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Voglivance GM 2mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is necessary before use. This medication is particularly unsuitable for individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Voglivance GM 2mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. Medical advice is essential. A reduced initial dose is usually prescribed for those with mild to moderate liver disease; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Voglivance GM 2mg/500mg/0.2mg Tablet :

Should you forget to take a Voglivance GM 2mg/500mg/0.2mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglivance GM 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Voglivance GM 2mg/500mg/0.2mg Tablet

Voglivance GM, a combined tablet containing Glimepiride 2mg, Metformin 500mg, and Voglibose 0.2mg, treats type 2 diabetes mellitus in adults. It improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; Metformin reduces liver glucose production and enhances insulin sensitivity; and Voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 diabetes.
Voglivance GM 2mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, taste changes, flatulence, abdominal pain, headache, rash, and respiratory infections.
Voglivance GM 2mg/500mg/0.2mg Tablets are contraindicated in patients with allergies to any component or excipient. This medication should also be avoided in those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Voglivance GM 2mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Voglivance GM 2mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Voglivance GM 2mg/500mg/0...
103
MRP 125
17% off